SYNGENE - Syngene International

Syngene International

SYNGENE · Pharma > Pharmaceuticals & Drugs · Chairman: Kiran Mazumdar Shaw · MD: Jonathan Hunt · Listing date: Aug. 11, 2015 · Employees: 5437 · Bangalore · http://www.syngeneintl.com

Stock Price vs Company Growth

0.2%

2.2%

5.8%

7.5%

35.6%

33.1%

6.2%

10y

7.2%

all

9.8%

🤔 How to analyze this graph?

Last Traded Price

₹ 422 0.2%

391

517

Company Overview

Sales

3,739 Cr

Growth: 2.8%

Profit after Tax

317 Cr

Growth: -10.1%

Mid Cap

17,033 Cr

P/E: 53.7x

Industry P/E: 33.7x

Fundamentals

Sales (Cr)	₹ 3,739
Growth	2.8%
EBITDA	24.6%
P/S	4.6x
Dividend	0.2%
P/E	53.7x
Book Value	₹ 120
PEG Ratio	19.4x
ROE	6.5%
P/B	3.6x

Shareholding Pattern

Institutions

Government Pension Fund Global

1.14 %

Uti-Mid Cap Fund

1.03 %

Qualified Institutional Buyer

0.15 %

Promoters

Biocon Limited

70.1 %

Biocon Limited Employee Welfare Trust (Murali Krishnan K N And Amitava Saha)

0.32 %

Yamini R Mazumdar

0.01 %

Others

Increase Decrease No change

Company Profile Detailed

The company is a contract research, development, and manufacturing services company that offers a broad range of scientific services from the earliest stages of discovery to commercial supplies. This positions the Company as an end-to-end service provider within its sector.

Belongs to (29 Indices) view more

Investors (435)

mahesh.g...

ajit.man...

ramakris...

Followers (15)

yogesh

nitin2

keerthi